All News #Library
Biotech
Biond Biologics Start Ph 2 Study Of BND-22 With Anti-PD-1 Therapy
08 Oct 2025 //
PR NEWSWIRE
Sanofi passes $125M ILT2 asset back to Biond Biologics
27 Feb 2025 //
FIERCE BIOTECH
Biond Biologics Announces Trial Collaboration With Merck KGaA
29 Oct 2024 //
PR NEWSWIRE
Biond Biologics Doses First Patient With BND-35 In Phase 1 Clinical Trial
24 Jun 2024 //
PR NEWSWIRE

Market Place
Sourcing Support